FindTrial
Sign In

Hemozoin Based Diagnostic Assay for Malaria Detection, Molecular Characterization

Evaluation of A Novel Hemozoin Based Diagnostic Assay for Detection of Malaria Parasites and Molecular Characterization of Plasmodium Species

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034787
Enrollment
695
Registered
2021-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B54- Unspecified malaria

Interventions

None listed

Sponsors

Hemex Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with fever, suspected to have malaria.

Exclusion criteria

Exclusion criteria: Patients who have received antimalarials.

Design outcomes

Primary

MeasureTime frame
Development and validation of of rapid and reliable point of care diagnostic for malariaTimepoint: First, Second and Third year—

Secondary

MeasureTime frame
Provide evidence for presence of Pfhrp2 and Pfhrp3 gene deletionsTimepoint: Second and Third year;Understanding the emergence and spread of the drug resistance in this regionTimepoint: Second and Third year—

Countries

India

Contacts

Public ContactNallapati Vishnu Teja

Kasturba Medical College

kavitha.saravu@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026